Cargando…

Long-term outcomes of non-metastatic breast cancer patients by molecular subtypes

BACKGROUND: Today, with the progress of medical sciences, increasing the cure probability and survival time is an important goal of cancer treatment. This study compared long-term disease-free survival (DFS) of non-metastatic breast cancer patients based on different molecular subtypes. METHODS: Thi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Fendereski, Afsaneh, Hajizadeh, Ebrahim, Haghighat, Shahpar, Rasekhi, Aliakbar
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2022
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9254545/ https://www.ncbi.nlm.nih.gov/pubmed/35787692 http://dx.doi.org/10.1186/s12905-022-01846-3

Ejemplares similares

Evaluation Factors Affecting on Recurrence, Metastasis, and Survival of Breast Cancer in Iranian Women by Multi-State Model Approach
por: Mousavi, Maryam, et al.
Publicado: (2023)

Modeling In Vitro Fertilization Data Considering Multiple Outcomes Observed among Iranian Infertile Women
por: Ghaheri, Azadeh, et al.
Publicado: (2018)

Investigation factors affecting the first recurrence of coronary artery disease in patients undergone angioplasty using cox survival model
por: Nasseryan, Javad, et al.
Publicado: (2016)

Identification of associated risk factors for the severity of generalized anxiety disorder among Iranian infertile people: An ordinal regression analysis with a flexible link function
por: Mohammadzadeh, Fatemeh, et al.
Publicado: (2019)

Determining Prognostic Factors of Disease-Free Survival in Breast Cancer Using Censored Quantile Regression
por: Yazdani, Akram, et al.
Publicado: (2022)

Association between Multiple Recurrent Events with Multivariate Modeling: A Retrospective Cohort Study
por: Osmani, Freshteh, et al.
Publicado: (2018)

Comparing the efficacy and side-effects of PDLASTA® (Pegfilgrastim) with PDGRASTIM® (Filgrastim) in breast cancer patients: a non-inferiority randomized clinical trial
por: Najafi, Safa, et al.
Publicado: (2021)

The comparison of censored quantile regression methods in prognosis factors of breast cancer survival
por: Yazdani, Akram, et al.
Publicado: (2021)

Survival analysis of recurrent breast cancer patients using mix Bayesian network
por: Shahmirzalou, Parviz, et al.
Publicado: (2023)

Long-term treatment patterns and survival in metastatic breast cancer by intrinsic subtypes – an observational cohort study in Sweden
por: Lindman, Henrik, et al.
Publicado: (2022)

Effectiveness of home-based exercise in breast cancer survivors: a randomized clinical trial
por: Farajivafa, Vahid, et al.
Publicado: (2023)

Effect of lymphedema self-management group-based education compared with social network-based education on quality of life and fear of cancer recurrence in women with breast cancer: a randomized controlled clinical trial
por: Omidi, Zahra, et al.
Publicado: (2020)

Outcomes following stereotactic radiosurgery or whole brain radiation therapy by molecular subtype of metastatic breast cancer
por: Haque, Waqar, et al.
Publicado: (2021)

Investigation of Prognostic Factors of Survival in Breast Cancer Using a Frailty Model: A Multicenter Study
por: Yazdani, Akram, et al.
Publicado: (2019)

Cost-Effectiveness of Three Rounds of Mammography Breast Cancer Screening in Iranian Women
por: Haghighat, Shahpar, et al.
Publicado: (2016)

Psychometric evaluation of the Persian version of the Lymphedema Life Impact Scale (LLIS, version 1) in breast cancer patients
por: Haghighat, Shahpar, et al.
Publicado: (2018)

Prediction of lymphedema occurrence in patients with breast cancer using the optimized combination of ensemble learning algorithm and feature selection
por: Yaghoobi Notash, Anaram, et al.
Publicado: (2022)

Application of Frailty Quantile Regression Model to Investigate of Factors Survival Time in Breast Cancer: A Multi-Center Study
por: Yazdani, Akram, et al.
Publicado: (2023)

De novo metastatic breast cancer: Subgroup analysis of molecular subtypes and prognosis
por: Zhang, Li, et al.
Publicado: (2020)

Status of breast cancer screening strategies and indicators in Iran: A scoping review
por: Omidi, Zahra, et al.
Publicado: (2022)

Long Term Survivor with Erlotinib in Metastatic Lung Cancer-Squamous Cell Carcinoma Subtype
por: VATU, BOGDAN IONEL, et al.
Publicado: (2020)

Development and validation of a guideline on sexual and reproductive health of breast cancer survivors in Iran: a mixed methods study protocol
por: Roshandel, Solmaz, et al.
Publicado: (2021)

Molecular subtypes of breast cancer in relation to paclitaxel response and outcomes in women with metastatic disease: results from CALGB 9342
por: Harris, Lyndsay N, et al.
Publicado: (2006)

The Effect of Complete Decongestive Therapy on Edema Volume Reduction and Pain in Women With Post Breast Surgery Lymph Edema
por: Angooti Oshnari, Leila, et al.
Publicado: (2016)

Molecular Subtypes and Personalized Therapy in Metastatic Colorectal Cancer
por: Graham, Donna M., et al.
Publicado: (2016)

Metastatic heterogeneity of the consensus molecular subtypes of colorectal cancer
por: Eide, Peter W., et al.
Publicado: (2021)

Retrospective analysis of metastatic behaviour of breast cancer subtypes
por: Savci-Heijink, C. Dilara, et al.
Publicado: (2015)

Non-Sentinel Lymph Node Metastasis Prediction in Breast Cancer with Metastatic Sentinel Lymph Node: Impact of Molecular Subtypes Classification
por: Reyal, Fabien, et al.
Publicado: (2012)

Involvement of hedgehog pathway in early onset, aggressive molecular subtypes and metastatic potential of breast cancer
por: Riaz, Syeda Kiran, et al.
Publicado: (2018)

Impact of molecular subtypes on metastatic breast cancer patients: a SEER population-based study
por: Gong, Yue, et al.
Publicado: (2017)

Factors responsible for long-term survival in metastatic breast cancer
por: Kontani, Keiichi, et al.
Publicado: (2014)

Breast carcinoma: molecular markers and subtypes to predict patients at risk of developing metastatic disease
por: Inderhaug, CR, et al.
Publicado: (2009)

Survival Rate of Breast Cancer Based on Geographical Variation in Iran, a National Study
por: Movahedi, Mohammad, et al.
Publicado: (2012)

Efficacy and safety of diphereline 11.25 mg, microrelin 11.25 mg, and microrelin 3.75 mg in premenopausal patients with breast cancer: a non-inferiority randomized clinical trial
por: Najafi, Safa, et al.
Publicado: (2023)

Structural Challenges of Providing Palliative Care for Patients with Breast Cancer
por: Khoshnazar, Tahereh Alsadat Khoubbin, et al.
Publicado: (2016)

Distinct outcomes in patients with different molecular subtypes of inflammatory breast cancer
por: Zhou, Jingyu, et al.
Publicado: (2014)

The Effect of Continuous Care Model on Blood Pressure and Quality of Life in Patients with Hypertension: A Randomized Clinical Trial
por: Sadeghi, Nasrin, et al.
Publicado: (2022)

Molecular subtypes and the evolution of treatment management in metastatic colorectal cancer
por: Martini, Giulia, et al.
Publicado: (2020)

Differentiation between metastatic and tumour-free cervical lymph nodes in patients with papillary thyroid carcinoma by grey-scale sonographic texture analysis
por: Ardakani, Ali Abbasian, et al.
Publicado: (2018)

Proteomics-derived basal biomarker DNA-PKcs is associated with intrinsic subtype and long-term clinical outcomes in breast cancer
por: Asleh, Karama, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_auji14c065mv4tc4q7ka1uujnv